AAAAAA

   
Results: 1-15 |
Results: 15
Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction
Authors: Gibson, CM Kirtane, AJ Murphy, SA Marble, SJ de Lemos, JA Antman, EM Braunwald, E
Citation: Cm. Gibson et al., Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction, CATHET C IN, 53(1), 2001, pp. 6-11
Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA)
Authors: Gibson, CM Marble, SJ
Citation: Cm. Gibson et Sj. Marble, Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA), CLIN CARD, 24(9), 2001, pp. 577-584
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction - A TIMI 14 substudy
Authors: Gibson, CM de Lemos, JA Murphy, SA Marble, SJ McCabe, CH Cannon, CP Antman, EM Braunwald, E
Citation: Cm. Gibson et al., Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction - A TIMI 14 substudy, CIRCULATION, 103(21), 2001, pp. 2550-2554
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytictrials?
Authors: Gibson, CM Murphy, SA Marble, SJ McCabe, CH Antman, EM Cannon, CP Braunwald, E
Citation: Cm. Gibson et al., Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytictrials?, AM J CARD, 87(4), 2001, pp. 450
Effect of Eptifibatide on coronary flow reserve following coronary stent implantation - (An ESPRIT substudy)
Authors: Gibson, CM Cohen, DJ Cohen, EA Lui, HK Murphy, SA Marble, SJ Kitt, M Lorenz, T Tcheng, JE
Citation: Cm. Gibson et al., Effect of Eptifibatide on coronary flow reserve following coronary stent implantation - (An ESPRIT substudy), AM J CARD, 87(11), 2001, pp. 1293-1295
Key references on a wide variety of topics pertaining to coronary artery blood flow and patency
Authors: Goel, M Marble, SJ Gibson, CM
Citation: M. Goel et al., Key references on a wide variety of topics pertaining to coronary artery blood flow and patency, J THROMB TH, 9(1), 2000, pp. 85-93
Is the corrected TIMI frame count an independent predictor of adverse outcome? Response
Authors: Gibson, CM Murphy, SA Rizzo, MJ Ryan, KA Marble, SJ McCabe, CH Cannon, CP Van de Werf, F Braunwald, E
Citation: Cm. Gibson et al., Is the corrected TIMI frame count an independent predictor of adverse outcome? Response, CIRCULATION, 102(2), 2000, pp. E19-E19
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
Authors: Gibson, CM Cannon, CP Murphy, SA Ryan, KA Mesley, R Marble, SJ McCabe, CH Van de Werf, F Braunwald, E
Citation: Cm. Gibson et al., Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs, CIRCULATION, 101(2), 2000, pp. 125-130
Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy)
Authors: Gibson, CM Goel, M Murphy, SA Dotani, I Marble, SJ Deckelbaum, LI Dodge, JT King, SB
Citation: Cm. Gibson et al., Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy), AM J CARD, 86(12), 2000, pp. 1375
Glycoprotein IIb IIIa receptor inhibition in interventional cardiology
Authors: Gibson, CM Moynihan, JL Al-Mousa, EN Campsey, M Gandhi, R Murphy, S Mattson, S Ryan, KA Mesley, R Swanson, J Arshad, MN Marble, SJ
Citation: Cm. Gibson et al., Glycoprotein IIb IIIa receptor inhibition in interventional cardiology, J THROMB TH, 7(3), 1999, pp. 287-300
Determinants of coronary blood flow after thrombolytic administration
Authors: Gibson, CM Murphy, S Menown, IBA Sequeira, RF Greene, R Van de Werf, F Schweiger, MJ Ghali, M Frey, MJ Ryan, KA Marble, SJ Giugliano, RP Antman, EM Cannon, CP Braunwald, E
Citation: Cm. Gibson et al., Determinants of coronary blood flow after thrombolytic administration, J AM COL C, 34(5), 1999, pp. 1403-1412
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction
Authors: Gibson, CM Ryan, KA Murphy, SA Mesley, R Marble, SJ Giugliano, RP Cannon, CP Antman, EM Braunwald, E
Citation: Cm. Gibson et al., Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction, J AM COL C, 34(4), 1999, pp. 974-982
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration
Authors: Gibson, CM Murphy, SA Rizzo, MJ Ryan, KA Marble, SJ McCabe, CH Cannon, CP Van de Werf, F Braunwald, E
Citation: Cm. Gibson et al., Relationship between TIMI frame count and clinical outcomes after thrombolytic administration, CIRCULATION, 99(15), 1999, pp. 1945-1950
Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results
Authors: Gibson, CM Ryan, KA Kelley, M Rizzo, MJ Mesley, R Murphy, S Swanson, J Marble, SJ Dodge, JT Giugliano, RP Cannon, CP Antman, EM
Citation: Cm. Gibson et al., Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results, AM HEART J, 137(6), 1999, pp. 1179-1184
Angiographic methods to assess human coronary angiogenesis
Authors: Gibson, CM Ryan, K Sparano, A Moynihan, JL Rizzo, M Kelley, M Marble, SJ Laham, R Simons, M McClusky, TR Dodge, JT
Citation: Cm. Gibson et al., Angiographic methods to assess human coronary angiogenesis, AM HEART J, 137(1), 1999, pp. 169-179
Risultati: 1-15 |